Blogs

The devastation produced by the earthquake, tsunami and subsequent nuclear crisis in Japan has affected drug and medical device companies there along with just about every other aspect of Japanese life. As life sciences companies and regulators assess the damage and formulate next steps, companies are scrambling to determine the impact on their operations, including manufacturing, supply chains and ongoing clinical trials. Device makers are calling for increased resources to be devoted to getting medical technology companies up and running again to address the medical needs of the population, and regulators abroad are proceeding cautiously with regard to products imported from Japan.

Japan earthquake: Medtech industry urges more electricity for device manufacturers (Mass Device)

Does Japan Tragedy Cause Re-Think on FDA Funding? (Eye on FDA)

FDA Will Monitor Japanese-Made Drugs as Well as Food for Radiation (WSJ Health Blog)

Shortages Loom For Electronic Materials (Chemical & Engineering News)

Japan disaster hits some medical device makers (Reuters)

Japan earthquake hurts medical device makers (Mass Device)

CROs report on Japan quake impact (in-Pharmatechnologist)

Quake's effects felt by medical device industry: reports (DOTmed)

Japan Earthquake Expected to Negatively Impact Device Companies (Becker’s Orthopedic & Spine)